AGP
GILD icon

Aspire Growth Partners’s Gilead Sciences GILD Stock Holding History

Aspire Growth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$271K Buy
1,947
+12
+0.6% +$1.68K 0.19% 99
2025
Q4 		$238K Buy
1,935
+12
+0.6% +$1.46K 0.17% 110
2025
Q3 		$213K Buy
1,923
+13
+0.7% +$1.48K 0.16% 113
2025
Q2 		$212K Buy
+1,910
New +$203K 0.17% 111

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Aspire Growth Partners's GILD Position: Q1 2026 in Review

Aspire Growth Partners increased its Gilead Sciences (GILD) stake by 0.62% in Q1 2026, buying an estimated $1.68K and bringing the position to 1,947 shares worth $271K. The position accounts for 0.19% of the portfolio, ranked #99.

Aspire Growth Partners first reported a position in GILD in Q2 2025 and has held it in 4 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Aspire Growth Partners held 1,947 shares of Gilead Sciences worth $271K as of Q1 2026.
  • Aspire Growth Partners bought 12 Gilead Sciences shares in Q1 2026, an estimated $1.68K.
  • Gilead Sciences made up 0.19% of Aspire Growth Partners's portfolio in Q1 2026, its #99 holding.
  • Aspire Growth Partners first reported a position in Gilead Sciences in Q2 2025 and has held it in 4 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Aspire Growth Partners's 13F filing for Q1 2026, filed 17 Apr 2026.